Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift

被引：0
|
作者：
Yun-Fan Liaw
机构：
[1] Chang Gung University College of Medicine,Liver Research Unit, Chang Gung Memorial Hospital
来源：
Hepatology International | 2019年 / 13卷
关键词：
Clinical relapse; Entecavir; Hepatitis flare; Hepatic decompenation; Sustained remission; Tenofovir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [1] Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
    Liaw, Yun-Fan
    HEPATOLOGY INTERNATIONAL, 2019, 13 (06) : 665 - 673
  • [2] Finite nucleos(t)ide analog therapy for functional cure in HBeAg-negative chronic hepatitis B: Recent development in the paradigm shift
    Liaw, Yun-Fan
    Papatheodoridis, George
    HEPATOLOGY, 2024,
  • [3] Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2011, 31 : 95 - 103
  • [4] Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2013, 33 : 151 - 156
  • [5] HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
    Vigano, Mauro
    Mangia, Giampaolo
    Lampertico, Pietro
    LIVER INTERNATIONAL, 2014, 34 : 120 - 126
  • [6] Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B
    Rinker, Franziska
    Zimmer, Christine L.
    zu Siederdissen, Christoph Hoener
    Manns, Michael P.
    Kraft, Anke R. M.
    Wedemeyer, Heiner
    Bjoerkstroem, Niklas K.
    Cornberg, Markus
    JOURNAL OF HEPATOLOGY, 2018, 69 (03) : 584 - 593
  • [7] HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues
    Lampertico, Pietro
    Colombo, Massimo
    LIVER INTERNATIONAL, 2009, 29 : 130 - 132
  • [8] Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues
    Manolakopoulos, Spilios
    Kranidioti, Hariklia
    Kourikou, Anastasia
    Deutsch, Melanie-Maria
    Triantos, Christos
    Tsolias, Chrysostomos
    Manesis, Emanuel K.
    Mathou, Nicoletta
    Alexopoulou, Alexandra
    Hadziyannis, Emilia
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2021, 41 (01) : 48 - 57
  • [9] Treatment of HBeAg-positive chronic hepatitis B with nucleos(t)ide analogues
    Leung, Nancy
    LIVER INTERNATIONAL, 2011, 31 : 85 - 89
  • [10] Predictors of therapeutic response to peginterferon α-2a and nucleos(t)ide analog combination therapy for HBeAg-negative chronic hepatitis B: 1-year follow-up after treatment
    Mimura, Shima
    Fujita, Koji
    Takuma, Kei
    Nakahara, Mai
    Oura, Kyoko
    Tadokoro, Tomoko
    Tani, Joji
    Morishita, Asahiro
    Ono, Masafumi
    Himoto, Takashi
    Masaki, Tsutomu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (06)
12345